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to our hospital with congestive heart fail-
ure. She had a 7.0 French dual-lumen
Hickman catheter through which she had
been receiving regular blood transfusions
and iron chelation treatment with defer-
oxamine. The heart failure was controlled
with diuretics and digoxin. Three days
after admission, she complained of fever
and chills and was treated empirically
with vancomycin and ceftazidime. No
obvious focus of infection was identified,
and blood counts showed only neutro-
philia ( cells/L). Nocardia as-914.0 10
teroides was isolated from blood samples
drawn simultaneously from both lumens
of the catheter and a peripheral vein. Be-
cause of lack of response, treatment was
changed to meropenem (100 mg/kg/day
iv for 3 weeks). The signs and symptoms
of infection subsided promptly and re-
sults of subsequent blood cultures were
negative. The catheter was retained.
Nocardia bacteremia complicating the
use of a central venous device is a rare
clinical event. Whether the indwelling
catheter should be removed immediately
deserves further discussion. In the case
we described in our previous report [2],
which was cited by Kontoyiannis et al.
[1], we managed to clear the infection
while the Hickman catheter was left in
situ. In their table 1, Kontoyiannis et al.
[1] incorrectly reported that the catheter
was removed; in fact, the catheter was only
removed 6 months later, when the patient
no longer required it. However, our suc-
cessful experience of retaining the central
venous catheter in catheter-associated no-
cardiosis may be different from others’
experiences. Both our patients were suf-
fering from thalassemia and were not
receiving chemotherapy at the time of in-
fection. The patients described by Kon-
tonyiannis et al. [1] and Miron et al. [3]
had malignant diseases and were receiv-
ing cytotoxics and radiotherapy (table 1).
Hence, we agree with Kontoyiannis et al.
that patients with catheter-associated no-
cardiosis should be carefully evaluated.
Removal of the catheter is not absolutely
indicated but should be seriously consid-
ered when the patient is receiving im-
munosuppressive therapy.
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Subacute Malaria
Due to Plasmodium
falciparum and the
Role of Polymerase
Chain Reaction
Sir—We read with interest the article by
Klement et al. [1] and would like to com-
ment on some issues raised in their paper.
We disagree with the conclusion that, for
the 4 patients the authors observed, “the
diagnosis of malaria could easily have been
missed because the clinical signs were un-
common” ([1], p. e1). It is, in fact, well-
known that for all subjects who have re-
cently returned from areas of endemicity,
regardless of whether they received pro-
phylaxis, clinicians should always suspect
malaria and perform the appropriate di-
agnostic tests until this diagnosis is either
confirmed or definitively ruled out. An
insidious presentation and “atypical”
symptoms, such as intermittent low-grade
fever, lumbosacral muscle pain, fatigue,
malaise, and nonspecific gastrointestinal
discomfort, as well as afebrile cases, have
been described elsewhere in patients with
malaria who had received chemoprophy-
laxis [2–4].
Furthermore, in 2 of the 4 patients de-
scribed by Klement et al. [1], intermittent
or low-grade fever was associated with
thrombocytopenia and elevated liver en-
zyme levels, which is highly suggestive of
malaria. In fact, thrombocytopenia, al-
though it is not pathognomonic, is a quite
frequent and early feature of malaria that
is found in at least 50%–70% of patients
[5]. In a case-control study performed to
identify signs and symptoms that predict
malaria infection in febrile patients who
had recently traveled to a area where ma-
laria is endemic, Svenson et al. [6] found
that a low platelet count had the strongest
association with the disease.
Moreover, the statement that “chloro-
quine-proguanil prophylaxis is not always
effective in countries with a low rate of
chloroquine resistance” ([1], p. e1) is not
new, since a lower efficacy (70%) of this
combination compared with mefloquine
was reported among travelers to East Af-
rica in 1993 [7]. We do not know whether
Senegal should be considered an area with
a low rate of chloroquine resistance; how-
ever, according to the advice issued by
both the World Health Organization and
the Centers for Disease Control and Pre-
vention, the drug of choice for malaria
prophylaxis in nonimmune travelers to
this country is mefloquine [8–9].
Finally, we agree with Klement et al. [1]
that PCR may be the best tool to reveal
subpatent parasitemia in cases similar to
those they described. With respect to this
point, from June 1996 through August
1999 we conducted a prospective study to
evaluate the use of PCR for the diagnosis
of malaria in patients who presented to
the emergency department of L. Sacco
Hospital in Milan, Italy, after returning
from areas where malaria is endemic and
experiencing symptoms suggestive of the
disease. We used a nested PCR protocol
targeted to a fragment of the small subunit
ribosomal RNA gene of Plasmodium spe-
cies that infect humans, as described by
Snounou et al. [10]. Blood film results
(both thin and thick smears) indicated
that 47 (40.8%) of 115 patients were in-
fected with malaria parasites. Among the
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Table 1. Utility of PCR for the diagnosis of malaria in 4 paradigmatic cases in Italian patients.
Patient
Age
in years,
sex
Countries visited
(length of stay) Prophylaxis Symptoms
Malaria test results
Microscopy PCR
1 57, M Kenya (1 week) Chloroquine,
proguanila
Low fever 7 days after return
(treated with acitamino-
phen); high fever (39C)
and chills on day 30
Negative from day 7 to day 10;
positive for Plasmodium fal-
ciparum on day 30 (0.5%
parasitemia)
Positive for P. falciparum
on day 9 (untreated)
2 26, M Tanzania and Kenya
(3 days)
None Fever (38C), headache, as-
thenia, and mild thrombo-
cytopenia 30 days after
return
Negative at onset and then for
3 days;b positive for Plasmo-
dium malariae on day 9
Positive for P. malariae
on day 6
3 50, F Central Africa
(8 months)
None High fever (39C) and chills
7 days after return; self-
treatment with sulfadox-
ine/pyrimethamine
Negative on day 1 after self-
treatmentc
Positive for P. falciparum
on day 1 after self-
treatment
4 34, M Cape Verde, Gambia,
and Senegal
(30 days)
Mefloquine Low fever, headache, and
mild thrombocytopenia 8
months after return
Negative for 2 days after on-
set; positive for Plasmodium
vivax on day 3
Positive for Plasmodium
ovale on day 2
a Prophylaxis stopped on return to Italy.
b Results of a MalaQuick test (ICT-malaria P.f.; Standby Diagnostics) were negative.
c Results of a MalaQuick test (ICT-malaria P.f.; Standby Diagnostics) were positive.
47 patients with acute malaria, parasite
morphology showed that 29 (61.7%) were
infected with Plasmodium falciparum, 11
(23.4%) with Plasmodium vivax, 4 (8.5%)
with Plasmodium ovale, 2 (4.2%) with
Plasmodium malariae, and 1 with both P.
falciparum and P. malariae. PCR analysis
confirmed the diagnosis of malaria in all
cases that were initially diagnosed by mi-
croscopy. A discordant diagnosis at the
species level between microscopy and PCR
was registered in 2 cases in which P. ovale
was initially misdiagnosed by microscopy
as P. vivax.
The use of PCR was particularly useful
for the 4 cases presented in Table 1. These
cases highlight the clinical situations in
which molecular amplification may aid in
the diagnosis of malaria: subpatent par-
asitemia associated with chemoprophy-
laxis (patient 1); malaria infection with
Plasmodia characterized by low levels of
parasitemia, such as P. malariae infection
(patient 2); diagnosis of malaria that is
confirmed during the convalescent period
(patient 3); and diagnosis of mixed infec-
tions unrecognized at onset with reap-
pearance of symptoms due to hypnozoite
(patient 4). However, because PCR has a
high cost and a high turnaround time
compared with microscopy performed by
well-trained personnel, the use of PCR for
the routine diagnosis of malaria in West-
ern countries is not advisable and should
be limited to selected cases.
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